Innoviva (INVA) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 206.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206.73% |
| Sep 30, 2025 | 134.90% |
| Mar 31, 2025 | 19.43% |
| Sep 30, 2024 | 21.59% |
| Mar 31, 2024 | -20.48% |
| Sep 30, 2023 | -28.47% |
| Mar 31, 2023 | 75.05% |
| Sep 30, 2022 | -175.37% |
| Jun 30, 2022 | -102.80% |
| Mar 31, 2022 | -442.38% |
| Sep 30, 2021 | 848.55% |
| Jun 30, 2021 | 1,386.01% |
| Mar 31, 2021 | -264.51% |
| Dec 31, 2020 | -706.76% |
| Sep 30, 2020 | 46.66% |
| Jun 30, 2020 | -134.81% |
| Mar 31, 2020 | 121.63% |
| Dec 31, 2019 | 214.04% |
| Sep 30, 2019 | -217.86% |
| Jun 30, 2019 | 121.49% |
| Mar 31, 2019 | -379.74% |
| Dec 31, 2018 | -76.17% |
| Sep 30, 2018 | 162.10% |
| Jun 30, 2018 | 348.74% |
| Mar 31, 2018 | 18.39% |
| Dec 31, 2017 | -210.98% |
| Sep 30, 2017 | -44.25% |
| Jun 30, 2017 | 108.26% |
| Mar 31, 2017 | 91.52% |
| Dec 31, 2016 | -76.51% |
| Sep 30, 2016 | 68.47% |
| Jun 30, 2016 | -171.96% |
| Mar 31, 2016 | -84.14% |
| Dec 31, 2015 | 1,280.45% |
| Sep 30, 2015 | 19.60% |
| Jun 30, 2015 | 403.05% |
| Mar 31, 2015 | 421.66% |
| Dec 31, 2014 | -489.83% |
| Sep 30, 2014 | 40.22% |
| Jun 30, 2014 | 84.72% |
| Mar 31, 2014 | 131.39% |
| Dec 31, 2013 | -1,076.71% |
| Sep 30, 2013 | -195.47% |
| Jun 30, 2013 | -122.15% |
| Mar 31, 2013 | -636.88% |
| Dec 31, 2012 | -96.79% |
| Sep 30, 2012 | -240.63% |
| Jun 30, 2012 | 32.76% |
| Mar 31, 2012 | 776.67% |
| Dec 31, 2011 | 125.21% |
| Sep 30, 2011 | -188.45% |